Japan clears Herceptin for breast cancer: Roche
ZURICH (Reuters) - Japan’s health authorities have approved Roche’s cancer drug Herceptin for the treatment of HER2-positive breast cancer, the Swiss drugmaker said on Friday.
More: continued here
Leave a Reply
You must be logged in to post a comment.